William Plovanic
Stock Analyst at Canaccord Genuity
(3.30)
# 1,054
Out of 5,150 analysts
176
Total ratings
42.41%
Success rate
4.34%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $127.95 | +54.75% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $242.89 | +79.09% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $30.99 | +71.02% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $112 → $109 | $72.21 | +50.95% | 15 | Feb 17, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $72.90 | +30.32% | 10 | Feb 13, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $11 → $10 | $8.49 | +17.79% | 10 | Feb 13, 2026 | |
| AORT Artivion | Maintains: Buy | $51 → $48 | $38.50 | +24.68% | 5 | Feb 13, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $23.41 | +49.51% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $147.66 | +0.23% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $5.00 | +140.00% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $89 → $87 | $85.22 | +2.09% | 30 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $17.77 | +68.82% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $40 | $23.93 | +67.15% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.99 | +63.79% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.33 | +426.32% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $90.46 | -0.51% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $95.75 | +5.48% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $8.47 | +77.10% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $339.61 | -16.37% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $13.00 | +92.31% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.44 | +733.33% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $74.16 | -5.61% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $19.22 | +149.74% | 5 | Aug 3, 2023 |
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $127.95
Upside: +54.75%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $242.89
Upside: +79.09%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $30.99
Upside: +71.02%
Boston Scientific
Feb 17, 2026
Maintains: Buy
Price Target: $112 → $109
Current: $72.21
Upside: +50.95%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $72.90
Upside: +30.32%
CVRx, Inc.
Feb 13, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $8.49
Upside: +17.79%
Artivion
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $38.50
Upside: +24.68%
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $23.41
Upside: +49.51%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $147.66
Upside: +0.23%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $5.00
Upside: +140.00%
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $85.22
Upside: +2.09%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $17.77
Upside: +68.82%
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $23.93
Upside: +67.15%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.99
Upside: +63.79%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.33
Upside: +426.32%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $90.46
Upside: -0.51%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $95.75
Upside: +5.48%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $8.47
Upside: +77.10%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $339.61
Upside: -16.37%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $13.00
Upside: +92.31%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.44
Upside: +733.33%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $74.16
Upside: -5.61%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $19.22
Upside: +149.74%